Data Pack

Rapid identification and development of SARS-CoV-2 selective Optimers®

Download Now

After clicking submit you will be emailed the link to access the application note.

.

Our application note details how we utilized our established Optimer selection and development processes to:

  • identify and develop Optimers targeting SARS-CoV-2 proteins in just 17 days.
  • demonstrate the superior performance of our Optimer reagents compared to commercially available antibodies and competitor aptamers to the same targets.
  • achieve highly consistent performance across different batches of SARS-CoV-2 specific Optimers.
  • evaluated Optimer performance across multiple analytical platforms.